Many immunostimulatory cytokines have been evaluated with tumor-cell vaccines, and granulocyte–macrophage colony-stimulating factor (GM-CSF) emerged as one of the most potent adjuvants in generating antitumor immunity (9, 10). This evidence concerns the gene CSF2 and neoplasm.